The Lancet Global Health in conversation with

Joe Bresee on influenza H5N1


Listen Later

Daniel Symons speaks to Dr Joe Bresee of the Task Force for Global Health on the threat posed by influenza H5N1, vaccine strategies, and strengthening systems to prepare for future epidemics and pandemics.

Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

...more
View all episodesView all episodes
Download on the App Store

The Lancet Global Health in conversation withBy The Lancet Group

  • 5
  • 5
  • 5
  • 5
  • 5

5

2 ratings


More shows like The Lancet Global Health in conversation with

View all
Planet Money by NPR

Planet Money

30,635 Listeners

Hidden Brain by Hidden Brain, Shankar Vedantam

Hidden Brain

43,567 Listeners

Global News Podcast by BBC World Service

Global News Podcast

7,698 Listeners

More or Less: Behind the Stats by BBC Radio 4

More or Less: Behind the Stats

889 Listeners

NEJM This Week by NEJM Group

NEJM This Week

318 Listeners

JAMA Clinical Reviews by JAMA Network

JAMA Clinical Reviews

496 Listeners

Diabetes Core Update by American Diabetes Association

Diabetes Core Update

100 Listeners

CrowdScience by BBC World Service

CrowdScience

482 Listeners

The Daily by The New York Times

The Daily

112,499 Listeners

Up First from NPR by NPR

Up First from NPR

56,383 Listeners

JAMA Medical News by JAMA Network

JAMA Medical News

85 Listeners

The Intelligence from The Economist by The Economist

The Intelligence from The Economist

2,540 Listeners

The Lancet Voice by The Lancet Group

The Lancet Voice

22 Listeners

The Lancet Child & Adolescent Health in conversation with by The Lancet Group

The Lancet Child & Adolescent Health in conversation with

0 Listeners

The Lancet Digital Health in conversation with by The Lancet Group

The Lancet Digital Health in conversation with

0 Listeners

The Lancet Oncology in conversation with by The Lancet Group

The Lancet Oncology in conversation with

1 Listeners

The Lancet Psychiatry in conversation with by The Lancet Group

The Lancet Psychiatry in conversation with

0 Listeners

The Lancet Respiratory Medicine in conversation with by The Lancet Group

The Lancet Respiratory Medicine in conversation with

1 Listeners

The Lancet in conversation with by The Lancet Group

The Lancet in conversation with

0 Listeners

The Lancet Haematology in conversation with by The Lancet Group

The Lancet Haematology in conversation with

0 Listeners

The Ezra Klein Show by New York Times Opinion

The Ezra Klein Show

15,991 Listeners

The Lancet Gastroenterology & Hepatology in conversation with by The Lancet Group

The Lancet Gastroenterology & Hepatology in conversation with

1 Listeners

The Lancet Diabetes & Endocrinology in conversation with by The Lancet Group

The Lancet Diabetes & Endocrinology in conversation with

1 Listeners

The Lancet Infectious Diseases in conversation with by The Lancet Group

The Lancet Infectious Diseases in conversation with

0 Listeners

The Lancet Public Health in conversation with by The Lancet Group

The Lancet Public Health in conversation with

1 Listeners

The Lancet Microbe in conversation with by The Lancet Group

The Lancet Microbe in conversation with

0 Listeners

eBioMedicine in conversation with by The Lancet Group

eBioMedicine in conversation with

0 Listeners

In conversation with... by The Lancet Neurology

In conversation with...

0 Listeners

The Rest Is Politics by Goalhanger

The Rest Is Politics

3,095 Listeners

The Rest Is Politics: US by Goalhanger

The Rest Is Politics: US

2,203 Listeners

The Lancet Rheumatology in conversation with by The Lancet Group

The Lancet Rheumatology in conversation with

0 Listeners

The Lancet Regional Health in conversation with by The Lancet Group

The Lancet Regional Health in conversation with

0 Listeners

The Lancet Primary Care in conversation with by The Lancet Group

The Lancet Primary Care in conversation with

0 Listeners

The Lancet Regional Health Americas in conversation with by The Lancet Group

The Lancet Regional Health Americas in conversation with

0 Listeners